Nuwiq recombinant and Polatuzumab Vedotin-piiq
Determining the interaction of Nuwiq recombinant and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nuwiq recombinant-Polio vaccine, inactivated
- Nuwiq recombinant-Poliovirus Vaccine (Inactivated)
- Nuwiq recombinant-Poliovirus vaccine, inactivated Injection
- Nuwiq recombinant-Polivy
- Nuwiq recombinant-Polmon
- Nuwiq recombinant-Polocaine
- Polatuzumab Vedotin-piiq-NuZole
- Polatuzumab Vedotin-piiq-Nuzyra
- Polatuzumab Vedotin-piiq-Nuzyra (Omadacycline Injection)
- Polatuzumab Vedotin-piiq-Nuzyra (Omadacycline Tablets)
- Polatuzumab Vedotin-piiq-Nuzyra Intravenous
- Polatuzumab Vedotin-piiq-Nuzyra oral/injection